Market Cap 199.31M
Revenue (ttm) 0.00
Net Income (ttm) -121.34M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.44
Volume 375,500
Avg Vol 1,022,836
Day's Range N/A - N/A
Shares Out 72.21M
Stochastic %K 72%
Beta 0.33
Analysts Strong Sell
Price Target $7.50

Company Profile

Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate Sabirnetug (ACU193), a recombinant humanized immunoglobulin gamma 2, which has completed the INTERCEPT-AD phase 1 clinical trial and in ALTITUDE-AD phase 2 clinical trial to target soluble amyloid-beta oligomers. It has a collaboration and license agreement with Halozyme, Inc. for t...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 344 4190
Address:
1210-1220 Washington St., Suite 210, Newton, United States
Billianas
Billianas Apr. 6 at 7:33 PM
0 · Reply
SmartMoneyTradez
SmartMoneyTradez Apr. 6 at 2:59 PM
$FF $ABOS $CRNC all green
0 · Reply
jacksparo
jacksparo Apr. 6 at 1:46 PM
$SLS $IBRX $ATOS $ABOS $OCGN Lets us see what today and this week will bring in ✅📈✅📈! I will taking all my needed notes for any possible updates 📈📈!
0 · Reply
SirBensonbot
SirBensonbot Apr. 3 at 12:27 AM
$ABOS long
0 · Reply
SmartMoneyTradez
SmartMoneyTradez Apr. 2 at 11:37 PM
$FF $ABOS $CRNC day 2 multis
0 · Reply
Billianas
Billianas Apr. 2 at 4:25 PM
$ABOS this one is definitely going under 1$ next few weeks
0 · Reply
jacksparo
jacksparo Apr. 2 at 2:22 PM
$SLS $IBRX $OCGN $NRXP $ABOS No panic at all , instead I am watching every single possible opportunity. The market can do whatever it wants. As long as my money in my pocket and I should be fine. Let’s us see how today goes! Remember no market tomorrow!
0 · Reply
outlawinvestor1
outlawinvestor1 Mar. 31 at 1:11 PM
$ABOS trading back down at approx fully diluted cash now + ra cap investment 2 weeks ago. i'm going to buy now.
0 · Reply
ForestFoxes
ForestFoxes Mar. 28 at 5:53 AM
$ANVS and her CEO, Dr. Maccecchini, brought about these two events via her dishonest business dealings and lack of ethics, IMO: 1️⃣ "Annovis Bio, Inc. Receives Continued Listing Standard Notice From the NYSE" https://www.annovisbio.com/press-release/annovis-bio-inc-receives-continued-listing-standard-notice-from-the-nyse 2️⃣ Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements https://s3.amazonaws.com/sec.irpass.cc/2990/0001104659-26-034611.pdf Warning to #MarkGuerin as Dr. Maccecchini likes to brag about firing her former CFOs to people she chats with. You will notice comments such as those posted on Stocktwits (here) such as: - "The CFO's employment history looks very suspicious?" - "Maybe she is blaming share slide on CFO." - "Why not dump them ... none so far have been useful in obtaining any funding. Rather let a non-performer go ... thy all had runs of 1 year here with zero cash influx." I know Dr. Maccecchini must have lied to Mark Guerin to induce his employment. Also, the comments blaming you and other former CFOs is very likely from Dr. Maccecchini making such innuendos to others. Dr. Maccecchini make false statements in her SEC filings as she told me she fired two of her former CFOs yet her SEC filings did NOT reflect these facts. I have also witnessed Dr. Maccecchini make material alterations to investment publications w/o required SEC filings. Dr. Maccecchini likely fights with all of her CFOs about her willfulness to ignore SEC filing protocols #SEC. Tagging $CGTX $ABOS $FLNA and $AVXL investors to warn them.
3 · Reply
ForestFoxes
ForestFoxes Mar. 27 at 6:35 PM
I knew $ANVS would burn through yet another CFO. Maybe the CEOs at $CGTX $ABOS $FLNA or $AVXL can help Dr. Maccecchini find a replacement. Then again, Dr. Maccecchini, states that she knows what she is doing and is proficient at doing this herself as to not get in trouble. At least that's my understanding of what she said in an email to me. The title of the article, "Annovis Bio CFO departs, CEO appointed as acting CFO" is Dr. Maccecchini's third time appointing herself as a replacement in this capacity. (The actual count may even be higher as I have lost count.) https://www.investing.com/news/sec-filings/intergroup-corp-completes-appointment-of-whitley-penn-llp-as-auditor-93CH-4585500 I didn't think that Mr. Mark Guerin would make it through the end of this year, 2026, but he didn't even make it through Q1. I am glad for his sake and her reputation that he has exited. Dr. Maccecchini will need to turn up the hype/embellishment ... or, flat out lie to lure her next financial officer to accept a position at Annovis Bio. I am surprised that Annovis Bio removed Mr. Guerin's from their website so quickly. Annovis Bio has in the past not done this and kept their website outdated, thus giving prospective shareholders the false impression that the company had an actual CFO. My demonstrative (see the 3rd attached image on this post) will need to be updated with Mr. Guerin. All of this was predictable given the behind the scenes activities by Dr. Maccecchini who is supported by her Chairman of the Board, Michael B. Hoffman. I will state for the record that I know how very little Dr. Maccecchini values the opinion and worth of her Scientific Advisory Board (SAB) and the members that consist of it, Dr. Sidney Stickland (SAB Chairman), Dr. Gregory Petsko (SAB Member), and Chief Medical Advisor and SAB Member, Jeffrey Commings, MD. Note: My comments and opinions are not slanderous as opined by some commenters as my statements are back by evidence and written proof in various formats, including emails received by Dr. Maccecchini herself and/or her executives.
2 · Reply
Latest News on ABOS
Lucy Therapeutics Appoints Kim Drapkin as Board Chair

Oct 15, 2024, 8:00 AM EDT - 1 year ago

Lucy Therapeutics Appoints Kim Drapkin as Board Chair

LENZ


Billianas
Billianas Apr. 6 at 7:33 PM
0 · Reply
SmartMoneyTradez
SmartMoneyTradez Apr. 6 at 2:59 PM
$FF $ABOS $CRNC all green
0 · Reply
jacksparo
jacksparo Apr. 6 at 1:46 PM
$SLS $IBRX $ATOS $ABOS $OCGN Lets us see what today and this week will bring in ✅📈✅📈! I will taking all my needed notes for any possible updates 📈📈!
0 · Reply
SirBensonbot
SirBensonbot Apr. 3 at 12:27 AM
$ABOS long
0 · Reply
SmartMoneyTradez
SmartMoneyTradez Apr. 2 at 11:37 PM
$FF $ABOS $CRNC day 2 multis
0 · Reply
Billianas
Billianas Apr. 2 at 4:25 PM
$ABOS this one is definitely going under 1$ next few weeks
0 · Reply
jacksparo
jacksparo Apr. 2 at 2:22 PM
$SLS $IBRX $OCGN $NRXP $ABOS No panic at all , instead I am watching every single possible opportunity. The market can do whatever it wants. As long as my money in my pocket and I should be fine. Let’s us see how today goes! Remember no market tomorrow!
0 · Reply
outlawinvestor1
outlawinvestor1 Mar. 31 at 1:11 PM
$ABOS trading back down at approx fully diluted cash now + ra cap investment 2 weeks ago. i'm going to buy now.
0 · Reply
ForestFoxes
ForestFoxes Mar. 28 at 5:53 AM
$ANVS and her CEO, Dr. Maccecchini, brought about these two events via her dishonest business dealings and lack of ethics, IMO: 1️⃣ "Annovis Bio, Inc. Receives Continued Listing Standard Notice From the NYSE" https://www.annovisbio.com/press-release/annovis-bio-inc-receives-continued-listing-standard-notice-from-the-nyse 2️⃣ Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements https://s3.amazonaws.com/sec.irpass.cc/2990/0001104659-26-034611.pdf Warning to #MarkGuerin as Dr. Maccecchini likes to brag about firing her former CFOs to people she chats with. You will notice comments such as those posted on Stocktwits (here) such as: - "The CFO's employment history looks very suspicious?" - "Maybe she is blaming share slide on CFO." - "Why not dump them ... none so far have been useful in obtaining any funding. Rather let a non-performer go ... thy all had runs of 1 year here with zero cash influx." I know Dr. Maccecchini must have lied to Mark Guerin to induce his employment. Also, the comments blaming you and other former CFOs is very likely from Dr. Maccecchini making such innuendos to others. Dr. Maccecchini make false statements in her SEC filings as she told me she fired two of her former CFOs yet her SEC filings did NOT reflect these facts. I have also witnessed Dr. Maccecchini make material alterations to investment publications w/o required SEC filings. Dr. Maccecchini likely fights with all of her CFOs about her willfulness to ignore SEC filing protocols #SEC. Tagging $CGTX $ABOS $FLNA and $AVXL investors to warn them.
3 · Reply
ForestFoxes
ForestFoxes Mar. 27 at 6:35 PM
I knew $ANVS would burn through yet another CFO. Maybe the CEOs at $CGTX $ABOS $FLNA or $AVXL can help Dr. Maccecchini find a replacement. Then again, Dr. Maccecchini, states that she knows what she is doing and is proficient at doing this herself as to not get in trouble. At least that's my understanding of what she said in an email to me. The title of the article, "Annovis Bio CFO departs, CEO appointed as acting CFO" is Dr. Maccecchini's third time appointing herself as a replacement in this capacity. (The actual count may even be higher as I have lost count.) https://www.investing.com/news/sec-filings/intergroup-corp-completes-appointment-of-whitley-penn-llp-as-auditor-93CH-4585500 I didn't think that Mr. Mark Guerin would make it through the end of this year, 2026, but he didn't even make it through Q1. I am glad for his sake and her reputation that he has exited. Dr. Maccecchini will need to turn up the hype/embellishment ... or, flat out lie to lure her next financial officer to accept a position at Annovis Bio. I am surprised that Annovis Bio removed Mr. Guerin's from their website so quickly. Annovis Bio has in the past not done this and kept their website outdated, thus giving prospective shareholders the false impression that the company had an actual CFO. My demonstrative (see the 3rd attached image on this post) will need to be updated with Mr. Guerin. All of this was predictable given the behind the scenes activities by Dr. Maccecchini who is supported by her Chairman of the Board, Michael B. Hoffman. I will state for the record that I know how very little Dr. Maccecchini values the opinion and worth of her Scientific Advisory Board (SAB) and the members that consist of it, Dr. Sidney Stickland (SAB Chairman), Dr. Gregory Petsko (SAB Member), and Chief Medical Advisor and SAB Member, Jeffrey Commings, MD. Note: My comments and opinions are not slanderous as opined by some commenters as my statements are back by evidence and written proof in various formats, including emails received by Dr. Maccecchini herself and/or her executives.
2 · Reply
ForestFoxes
ForestFoxes Mar. 27 at 4:46 PM
IMO, I am not being slanderous or derogatory against the CEO of $ANVS Dr. Maccecchini as my statements are factual and tangible evidence. Her business ethics and her moral character should come into question by all. Is she really focused on accessing the capital markets (which was my only goal in helping her until the reality was understood) or is her goal to fleece investors with this game she has setup of boost her ego??? Is she really trying to deliver a life saving treatment for patients worldwide ... or, is she blowing smoke up shareholders and patients with story of global support (which no capital entities believes)? She bragged that other countries would support her for her Phase 3 studies as if that was low hanging fruit. It's BS. This is the way that Dr. Maccecchini rolls. She's perfectly happy deceiving both shareholders and patients alike. She's happy to share stories with me about firing CFOs. She likes to yell at people and blame contractors, including yelling at Clinical Research Organization representatives for mistakes for her own lack of patient screening protocols and drug trial design flaws. And, absolutely investors from other stocks in this space such as $CGTX $ABOS $FLNA $AVXL and others such steer clear of Annovis Bio and warn others. This post is a continuation of the threads below: https://stocktwits.com/ForestFoxes/message/648597144 https://stocktwits.com/ForestFoxes/message/648771056
2 · Reply
vrstock23
vrstock23 Mar. 27 at 3:57 PM
$ABOS so this is same investors who bought 10,833,331 shares at $3.30 registering for resale. So I guess, they would like to sell over $3.30, so can we expect some PR after effective? What PR company can release? Or probably registering for time near data release near year end?
0 · Reply
OpenOutcrier
OpenOutcrier Mar. 27 at 12:39 PM
$ABOS (-10.2% pre) Acumen Pharmaceuticals, Inc (ABOS) files for 10.83M share offering by selling stockholders - SI https://ooc.bz/l/97477
0 · Reply
jacksparo
jacksparo Mar. 27 at 2:47 AM
$RCKT The recent FDA approval will serve as the initial step in a series of forthcoming catalysts, signaling the onset of a new era for this stock. This stock will be included in my regularly updated list of promising biotech equities in my Live Biotech group, alongside $SLS, $IBRX, $OCGN, and $ABOS. I look forward to observing the market developments that tomorrow will bring. GL everyone in my incredible team and my beloved followers!
2 · Reply
jlove0303
jlove0303 Mar. 26 at 8:37 PM
$ABOS offering
0 · Reply
kil0gho5t
kil0gho5t Mar. 26 at 7:19 PM
$ABOS $IBRX $NRXP $OCGN $SLS He looked at my account and im a “short trader” then blocked before i can reply. Oh well just 650% and 170% long trades he must not of counted them as the percentages was wat higher than anything jack provides 😂😂
0 · Reply
Johnkerby1988
Johnkerby1988 Mar. 26 at 7:16 PM
$SLS $IBRX $OCGN $ABOS $NRXP Have anyone checked your account? Basically, you are a short trader. You are bad-mouthing Jack for no reason other than you are shorting stocks, and anyone who checks his account and posts will see that. What a piece of shit, maybe as Jack told me, just blocking you is the best practice!
0 · Reply
kil0gho5t
kil0gho5t Mar. 26 at 6:36 PM
$ABOS $IBRX $NRXP $OCGN $SLS another jacksparo alt account look at his following and who he follows convenient they are the same people who love jack and reshare his shameless canvassing. Let me ask you if you was making thousands per day trading could you be bothered with all the marketing and nonsense to get 500 bucks from 1 sign up. Traders on youtube make money from content traders with groups make money from front loading and sign ups. The genuine ones wont need your cash i promise you that 😂
3 · Reply
Johnkerby1988
Johnkerby1988 Mar. 26 at 5:38 PM
$SLS $IBRX $OCGN $ABOS $NRXP Great, let us buy the dip, Jack! You are among the only few I like to follow in Stocktwits!
0 · Reply
jacksparo
jacksparo Mar. 26 at 4:25 PM
$SLS $IBRX $OCGN $ABOS $NRXP I will share some important updates about: The weekly chart update will most likely be by the end of the week, tomorrow! What will my plan be for next week? The new risk vs reward scale! The monthly chart will also be shown next week with a major update! Let us stay focused and avoid the noise around! All my Live updates about Biotech stocks will be shared in my Live Biotech Group! Enjoy the rest of your day!
1 · Reply
StocktwitsEarnings
StocktwitsEarnings Mar. 26 at 12:39 PM
$ABOS Q4 '25 Earnings Results & Recap Acumen expects topline results for its Phase 2 ALTITUDE-AD study in late 2026 and targets an IND filing for its lead EBD program candidate in mid-2027. Acumen's $116.9 million cash supports activities into early 2027.
0 · Reply
ForestFoxes
ForestFoxes Mar. 26 at 9:06 AM
I'm sorry about today's outcome for patients and shareholders of $AVXL and catching up on comments from other channels such as $CGTX and $ABOS and others discussing this. I am touched by Jesse Silveira's "Letter to Readers". No doubt people from the $ANVS channel will post about Annovis' drug being the best hoping to buoy their stock price. Because of this, I wanted to add my comments about my experience with Dr. Maccecchini, CEO of Annovis ☣️ Bio as a warning to other investors and people with loved ones affected by Alzheimer's, Parkinson's, and other neurological diseases. I am hopeful for progress in this field ❤️
4 · Reply